Literature DB >> 11552036

Long-term follow-up of neurosarcoidosis.

D Ferriby1, J de Seze, T Stojkovic, E Hachulla, B Wallaert, A Destée, P Y Hatron, P Vermersch.   

Abstract

The authors evaluated the long-term clinical outcome of neurosarcoidosis and determined predictive factors of disease course. Twenty-seven patients with neurosarcoidosis were followed for at least 5 years from the onset of neurologic symptoms. Patients with CNS involvement during the course of the disease had a higher Modified Oxford Handicap Scale score than those with peripheral nervous system involvement (p < 0.02). CNS involvement may be a predictive factor for a less favorable disease course. Early and intensive treatment should be considered in such cases.

Entities:  

Mesh:

Year:  2001        PMID: 11552036     DOI: 10.1212/wnl.57.5.927

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

1.  Long-term outcomes of refractory neurosarcoidosis treated with infliximab.

Authors:  Fleur Cohen Aubart; Diane Bouvry; Damien Galanaud; Caroline Dehais; Guillaume Mathey; Dimitri Psimaras; Julien Haroche; Corinne Pottier; Miguel Hie; Alexis Mathian; Hervé Devilliers; Hilario Nunes; Dominique Valeyre; Zahir Amoura
Journal:  J Neurol       Date:  2017-03-04       Impact factor: 4.849

Review 2.  Inflammatory neuropathies: an update on evaluation and treatment.

Authors:  Lisa D Hobson-Webb; Peter D Donofrio
Journal:  Curr Rheumatol Rep       Date:  2005-10       Impact factor: 4.592

3.  Diagnosis and Treatment in Neurosarcoidosis.

Authors:  Gökçen Gözübatik-Çelik; Uğur Uygunoğlu; Derya Uludüz; Ersan Atahan; Benan Müsellim; Sabahattin Saip; Aksel Siva
Journal:  Noro Psikiyatr Ars       Date:  2015-03-01       Impact factor: 1.339

4.  Sarcoidosis of the central nervous system: clinical features, imaging, and CSF results.

Authors:  Desmond P Kidd
Journal:  J Neurol       Date:  2018-06-19       Impact factor: 4.849

5.  Neurosarcoidosis. Clinical description of 7 cases with a proposal for a new diagnostic strategy.

Authors:  Sabrina Marangoni; Vincenza Argentiero; Bruno Tavolato
Journal:  J Neurol       Date:  2005-11-14       Impact factor: 4.849

6.  Treatment of CNS sarcoidosis with infliximab and mycophenolate mofetil.

Authors:  Michael Moravan; Benjamin M Segal
Journal:  Neurology       Date:  2009-01-27       Impact factor: 9.910

Review 7.  Sarcoidosis presenting as "corset-like" myelopathy: a description of six cases and literature review.

Authors:  Merav Lidar; Amir Dori; Yair Levy; Zvi Lidar; Joab Chapman; Pnina Langevitz
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

8.  Neuro-ophthalmologic Manifestations of Sarcoidosis.

Authors:  Barney J Stern; James Corbett
Journal:  Curr Treat Options Neurol       Date:  2007-01       Impact factor: 3.598

9.  Neurosarcoidosis.

Authors:  Kenkichi Nozaki; Marc A Judson
Journal:  Curr Treat Options Neurol       Date:  2013-08       Impact factor: 3.598

10.  [64-year old woman patient with severe pain and alterations of sensibility].

Authors:  P von Wichert; C Seifart
Journal:  Internist (Berl)       Date:  2003-07       Impact factor: 0.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.